R&D Systems™ Recombinant Rat B7-1/CD80 Fc Chimera Protein, CF
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Manufacturer: R&D Systems™ 1214B7050
DescriptionMeasured by its ability to induce IL-2 secretion by Jurkat human acute T cell leukemia cells. Freeman, G.J. et al. (1993) Science 262:909. The ED50 for this effect is 0.1-0.4 μg/mL in the presence of PHA.
|B7-1/CD80 Fc Chimera|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.|
|<0.10 EU / 1 µg of the protein by the LAL method.|
|Reconstitute at 100 µg/mL in sterile PBS.|
|Lyophilized from a 0.2 µm filtered solution in PBS.|
|M.W. (Observed): 80-90 kDa, reducing conditions; M.W. (theoretical): 50.5 kDa (monomer)|
|>90%, by SDS-PAGE under reducing conditions and visualized by silver stain|
|Mouse myeloma cell line, NS0-derived rat B7-1/CD80 protein Rat B7-1 (Ile39 - Gln248) (N-terminus) Accession # AAB60503 IEGRMD Human IgG1 (Pro100 - Lys330) (C-terminus)|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok